iBio Inc (IBIO)
2.00
+0.01
(+0.50%)
USD |
NYAM |
May 06, 16:00
2.00
0.00 (0.00%)
After-Hours: 18:21
iBio Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| June 30, 2022 | 1.884M |
| June 30, 2021 | 2.371M |
| June 30, 2020 | 1.638M |
| June 30, 2019 | 2.018M |
| June 30, 2018 | 0.444M |
| June 30, 2017 | 0.394M |
| June 30, 2016 | 0.948M |
| June 30, 2015 | 1.851M |
| Date | Value |
|---|---|
| June 30, 2014 | 0.205M |
| June 30, 2013 | 1.007M |
| June 30, 2012 | 1.277M |
| June 30, 2011 | 0.5201M |
| June 30, 2010 | |
| June 30, 2009 | 1.177M |
| June 30, 2008 | 0.9871M |
| June 30, 2007 | 0.8963M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.638M
Minimum
2020
2.371M
Maximum
2021
1.978M
Average
1.951M
Median
Revenue (Annual) Benchmarks
| Lixte Biotechnology Holdings Inc | -- |
| PAVmed Inc | 2.452M |
| Avalo Therapeutics Inc | 1.924M |
| Imunon Inc | -- |
| Ocugen Inc | 6.036M |